Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
- DOI
- 10.1212/wnl.0000000000003217
- Published
- 2016 Nov 15
- Container
- Neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1212/wnl.0000000000003217,
title = {Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.},
author = {Griggs RC and Miller JP and Greenberg CR and Fehlings DL and Pestronk A and Mendell JR and Moxley RT 3rd and King W and Kissel JT and Cwik V and Vanasse M and Florence JM and Pandya S and Dubow JS and Meyer JM},
year = {2016},
journal = {Neurology},
doi = {10.1212/wnl.0000000000003217},
url = {https://doi.org/10.1212/wnl.0000000000003217}
}RIS
TY - JOUR TI - Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy. AU - Griggs RC AU - Miller JP AU - Greenberg CR AU - Fehlings DL AU - Pestronk A AU - Mendell JR AU - Moxley RT 3rd AU - King W AU - Kissel JT AU - Cwik V AU - Vanasse M AU - Florence JM AU - Pandya S AU - Dubow JS AU - Meyer JM PY - 2016 JO - Neurology DO - 10.1212/wnl.0000000000003217 UR - https://doi.org/10.1212/wnl.0000000000003217 ER -
APA
RC, G., JP, M., CR, G., DL, F., A, P., JR, M., 3rd, M. R., W, K., JT, K., V, C., M, V., JM, F., S, P., JS, D., & JM, M. (2016). Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.. Neurology. https://doi.org/10.1212/wnl.0000000000003217
Source records
- pubmed · retrieved 2026-09-26T21:29:20.466Z